A conditionally replicating adenovirus carrying interleukin-24 sensitizes melanoma cells to radiotherapy via apoptosis

Molecular Oncology

Volumn 6, Issue 4, 2012, Pages 383-391

  Jiang, Guan ^a,b   Zhang, Kai ^a   Jiang, Ai Jun ^a   Xu, Dan ^a   Xin, Yong ^a   Wei, Zhi Ping ^a   Zheng, Jun Nian ^a   Liu, Yan Qun ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Center for Disease Control and Prevention of Xuzhou City   (China)

Author keywords

Apoptosis; Conditionally replicating adenoviruses; Interleukin 24; Melanoma; Radiation

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; E1A PROTEIN; INTERLEUKIN 24; PROTEIN BAX; PROTEIN BCL 2;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; EXPERIMENTAL MELANOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; VIRUS REPLICATION;

ADENOVIRIDAE;

EID: 84864297532     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.05.001     Document Type: Article

References (36)

1. Bieler A., Mantwill K., Holzmuller R., Jurchott K., Kaszubiak A., Stark S., Glockzin G., Lage H., Grosu A.L., Gansbacher B., Holm P.S. Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastoma. Radiother. Oncol. 2008, 86:419-427.
2. Chada S., Mhashilkar A.M., Liu Y., Nishikawa T., Bocangel D., Zheng M., Vorburger S.A., Pataer A., Swisher S.G., Ramesh R., Kawase K., Meyn R.E., Hunt K.K. mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members. Cancer Gene Ther. 2006, 13:490-502.
3. Chen Y., DeWeese T., Dilley J., Zhang Y., Li Y., Ramesh N., Lee J., Pennathur-Das R., Radzyminski J., Wypych J., Brignetti D., Scott S., Stephens J., Karpf D.B., Henderson D.R., Yu D.C. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. Cancer Res. 2001, 61:5453-5460.
4. Chu R.L., Post D.E., Khuri F.R., Van Meir E.G. Use of replicating oncolytic adenoviruses in combination therapy for cancer. Clin. Cancer Res. 2004, 10:5299-5312.
5. Cody J.J., Douglas J.T. Armed replicating adenoviruses for cancer virotherapy. Cancer Gene Ther. 2009, 16:473-488.
6. Datta R., Rubin E., Sukhatme V., Qureshi S., Hallahan D., Weichselbaum R.R., Kufe D.W. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10149-10153.
7. Eager R., Harle L., Nemunaitis J. Ad-MDA-7; INGN 241: a review of preclinical and clinical experience. Expert Opin. Biol. Ther. 2008, 8:1633-1643.
8. Eberle J., Fecker L.F., Hossini A.M., Kurbanov B.M., Fechner H. Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma. Exp. Dermatol. 2008, 17:1-11.
9. Eberle J., Kurbanov B.M., Hossini A.M., Trefzer U., Fecker L.F. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches. Drug Resist. Updat. 2007, 10:218-234.
10. Emdad L., Lebedeva I.V., Su Z.Z., Gupta P., Sauane M., Dash R., Grant S., Dent P., Curiel D.T., Sarkar D., Fisher P.B. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol. Ther. 2009, 8:391-400.
11. Emdad L., Sarkar D., Lebedeva I.V., Su Z.Z., Gupta P., Mahasreshti P.J., Dent P., Curiel D.T., Fisher P.B. Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer. J. Cell. Physiol. 2006, 208:298-306.
12. Fisher P.B. Is mda-7/IL-24 a "magic bullet" for cancer?. Cancer Res. 2005, 65:10128-10138.
13. Fisher P.B., Sarkar D., Lebedeva I.V., Emdad L., Gupta P., Sauane M., Su Z.Z., Grant S., Dent P., Curiel D.T., Senzer N., Nemunaitis J. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Toxicol. Appl. Pharmacol. 2007, 224:300-307.
14. Freytag S.O., Barton K.N., Brown S.L., Narra V., Zhang Y., Tyson D., Nall C., Lu M., Ajlouni M., Movsas B., Kim J.H. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer. Mol. Ther. 2007, 15:1600-1606.
15. Freytag S.O., Stricker H., Pegg J., Paielli D., Pradhan D.G., Peabody J., DePeralta-Venturina M., Xia X., Brown S., Lu M., Kim J.H. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res. 2003, 63:7497-7506.
16. Geoerger B., Grill J., Opolon P., Morizet J., Aubert G., Lecluse Y., van Beusechem V.W., Gerritsen W.R., Kirn D.H., Vassal G. Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br. J. Cancer 2003, 89:577-584.
17. Hakkarainen T., Rajecki M., Sarparanta M., Tenhunen M., Airaksinen A.J., Desmond R.A., Kairemo K., Hemminki A. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter. Clin. Cancer Res. 2009, 15:5396-5403.
18. Idema S., Lamfers M.L., van Beusechem V.W., Noske D.P., Heukelom S., Moeniralm S., Gerritsen W.R., Vandertop W.P., Dirven C.M. AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy. J. Gene Med. 2007, 9:1046-1056.
19. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 2007, 57:43-66.
20. Jiang G., Liu Y.Q., Wei Z.P., Pei D.S., Mao L.J., Zheng J.N. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. Cancer Lett. 2010, 294:220-228.
21. Jiang G., Xin Y., Zheng J.N., Liu Y.Q. Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach. Int. J. Cancer 2011, 129:263-274.
22. Jin G.H., Jin S.Z., Liu Y., Xu R.M., Yang J.Z., Pan X.N., Liu S.Z. Therapeutic effect of gene-therapy in combination with local X-irradiation in a mouse malignant melanoma model. Biochem. Biophys. Res. Commun. 2005, 330:975-981.
23. Kim J., Kim P.H., Yoo J.Y., Yoon A.R., Choi H.J., Seong J., Kim I.W., Kim J.H., Yun C.O. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect. Gene Ther. 2009, 16:1111-1121.
24. Lamfers M.L., Grill J., Dirven C.M., Van Beusechem V.W., Geoerger B., Van Den Berg J., Alemany R., Fueyo J., Curiel D.T., Vassal G., Pinedo H.M., Vandertop W.P., Gerritsen W.R. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy. Cancer Res. 2002, 62:5736-5742.
25. Lesinski G.B., Raig E.T., Guenterberg K., Brown L., Go M.R., Shah N.N., Lewis A., Quimper M., Hade E., Young G., Chaudhury A.R., Ladner K.J., Guttridge D.C., Bouchard P., Carson W.E. IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis. Cancer Res. 2008, 68:8351-8360.
26. National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, D.C.
27. Nishikawa T., Munshi A., Story M.D., Ismail S., Stevens C., Chada S., Meyn R.E. Adenoviral-mediated mda-7 expression suppresses DNA repair capacity and radiosensitizes non-small-cell lung cancer cells. Oncogene 2004, 23:7125-7131.
28. Qian W., Liu J., Tong Y., Yan S., Yang C., Yang M., Liu X. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis. Leukemia 2008, 22:361-369.
29. Rein D.T., Breidenbach M., Curiel D.T. Current developments in adenovirus-based cancer gene therapy. Future Oncol. 2006, 2:137-143.
30. Rogulski K.R., Freytag S.O., Zhang K., Gilbert J.D., Paielli D.L., Kim J.H., Heise C.C., Kirn D.H. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy. Cancer Res. 2000, 60:1193-1196.
31. Su Z.Z., Lebedeva I.V., Sarkar D., Emdad L., Gupta P., Kitada S., Dent P., Reed J.C., Fisher P.B. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene 2006, 25:2339-2348.
32. Weichselbaum R.R., Hallahan D.E., Sukhatme V.P., Kufe D.W. Gene therapy targeted by ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys. 1992, 24:565-567.
33. Yacoub A., Hamed H., Emdad L., Dos Santos W., Gupta P., Broaddus W.C., Ramakrishnan V., Sarkar D., Shah K., Curiel D.T., Grant S., Fisher P.B., Dent P. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. Cancer Biol. Ther. 2008, 7:917-933.
34. Yoon A.R., Kim J.H., Lee Y.S., Kim H., Yoo J.Y., Sohn J.H., Park B.W., Yun C.O. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin. Hum. Gene Ther. 2006, 17:379-390.
35. Zhao L., Dong A., Gu J., Liu Z., Zhang Y., Zhang W., Wang Y., He L., Qian C., Qian Q., Liu X. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther. 2006, 13:1011-1022.
36. Zhao L., Gu J., Dong A., Zhang Y., Zhong L., He L., Wang Y., Zhang J., Zhang Z., Huiwang J., Qian Q., Qian C., Liu X. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum. Gene Ther. 2005, 16:845-858.